Thoratec Company Profile (NASDAQ:THOR)

About Thoratec

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: THOR
  • CUSIP: 88517530
Key Metrics:
  • Previous Close: $63.50
  • 50 Day Moving Average: $63.03
  • 200 Day Moving Average: $51.62
  • 52-Week Range: $25.04 - $63.51
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 39.44
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Thoratec:

Analyst Ratings

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Thoratec (NASDAQ:THOR)
DateFirmActionRatingPrice TargetDetails
12/3/2015J P Morgan Chase & CoReiterated RatingNeutral$36.00 -> $43.00View Rating Details
11/2/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $45.00View Rating Details
11/2/2015Canaccord GenuityBoost Price TargetBuy$39.00 -> $41.00View Rating Details
10/14/2015Goldman Sachs Group, Inc. (The)UpgradeHoldView Rating Details
9/29/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$56.00 -> $60.00View Rating Details
9/25/2015BTIG ResearchReiterated RatingNeutralView Rating Details
8/24/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Wells Fargo & CoDowngradeOutperform -> Market PerformView Rating Details
7/22/2015Northland SecuritiesDowngradeOutperform -> Market Perform$55.00 -> $63.50View Rating Details
7/15/2015Oppenheimer Holdings, Inc.Boost Price TargetOutperform$49.00 -> $52.00View Rating Details
5/8/2015Barclays PLCBoost Price TargetEqual Weight$40.00 -> $43.00View Rating Details
3/3/2015Credit Suisse GroupSet Price TargetBuy$45.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Thoratec (NASDAQ:THOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details
8/1/2012$0.45$0.45ViewN/AView Earnings Details
5/1/2012$0.41$0.61ViewN/AView Earnings Details
11/1/2011$0.33$0.41ViewN/AView Earnings Details
8/3/2011$0.35$0.44ViewN/AView Earnings Details
5/3/2011$0.33$0.34ViewN/AView Earnings Details
1/27/2011$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thoratec (NASDAQ:THOR)
Current Year EPS Consensus Estimate: $1.37 EPS
Next Year EPS Consensus Estimate: $1.61 EPS


Dividend History for Thoratec (NASDAQ:THOR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Thoratec (NASDAQ:THOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Thoratec (NASDAQ:THOR)
News IconArtificial Organ And Bionics Market Will Grow At An Estimated CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. (NASDAQ:THOR) - February 22 at 10:19 AM
News IconKamagra pills - Order cheap kamagra, Kamagra for sale in the uk, Buy kamagra online ireland (NASDAQ:THOR) - February 19 at 8:36 AM
News IconBETTER ONLINE PHARMACY - Good rx, Caremark pharmacy, Roadrunner pharmacy (NASDAQ:THOR) - February 19 at 8:36 AM
News IconClaritin price - Claritin d coupons, Loratidine, Claritin generic (NASDAQ:THOR) - February 18 at 9:09 AM
News IconViagra for men - Sildenafil 20 mg tablet, Buy viagra from canada, Generic viagra sale usa (NASDAQ:THOR) - February 18 at 9:09 AM
News IconCialis without a doctor prescription - Tadalafil tablets, Cialis discount card, Buy daily cialis (NASDAQ:THOR) - February 18 at 9:09 AM
News IconBuy Kamagra Online - Buy kamagra cheap, Buy viagra kamagra online, Buy cheap kamagra gel (NASDAQ:THOR) - February 17 at 7:04 PM logoFuture and Growth of Global Artificial Organs Market by 2026 (NASDAQ:THOR) - February 17 at 7:04 PM
News IconCialis For Sale - Cheapest cialis price, Buy eli lilly cialis, Cialis 20 mg film-coated tablets tadalafil (NASDAQ:THOR) - February 17 at 7:04 PM logoCardiac Assist Devices Market Analysis, Segments, Growth and Value Chain 2015-2025 (NASDAQ:THOR) - February 16 at 8:04 PM logoTop Funds' New Buys: GrubHub Delivers Food, Profit (NASDAQ:THOR) - February 4 at 4:01 AM logoSunshine Heart Appoints Steve Brandt and Matthew E. Likens to Board of Directors (NASDAQ:THOR) - February 3 at 6:39 AM
News IconGlobal Artificial Organs Market Will Continue to Grow by 2026 (NASDAQ:THOR) - January 31 at 3:55 AM logoGlobal Congestive Heart Failure (CHF) Treatment Devices Market Analysis & Trends - Industry Forecast to 2025 - Research and Markets (NASDAQ:THOR) - January 28 at 6:56 AM logoAnalysis and Growth of Global Artificial Organs Market by 2026 (NASDAQ:THOR) - January 23 at 11:43 PM
News IconCardiac Assist Devices Market Growth, Trends and Value Chain 2015-2025 by FMI (NASDAQ:THOR) - January 19 at 4:41 AM
News IconLVADs 'Relatively Low Value' in Cost Analysis (NASDAQ:THOR) - January 12 at 3:06 AM logoArtificial Organs Market Is Expected to Witness a Steady Growth By 2026 (NASDAQ:THOR) - January 9 at 2:49 AM
News IconFMI Releases New Report on the Cardiac Assist Devices Market 2015-2025 (NASDAQ:THOR) - January 7 at 6:01 AM logoHow Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? (NASDAQ:THOR) - January 4 at 6:31 AM logoThoratec Acquisition: The Impact on St. Jude’s Growth Potential (NASDAQ:THOR) - January 4 at 6:31 AM
News IconCardiac Assist Devices Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2019 (NASDAQ:THOR) - January 2 at 7:55 PM
News IconBuy Levitra No Prescription - Levitra medication, Order generic levitra, Levitra buy generic, Cheapest levitra online (NASDAQ:THOR) - January 1 at 11:22 PM
News IconBuy CIALIS No Prescription - Can i buy cialis in usa, Buy cialis cheap canada - 4046 orders completed today (NASDAQ:THOR) - December 28 at 8:03 PM
News IconInsights of Cardiac Assist Devices South Korea Industry : Development and Forecast 2016-2020 (NASDAQ:THOR) - December 28 at 8:03 PM
News IconArtificial Organs Market Market will Generate New Growth Opportunities By 2015 to 2021 (NASDAQ:THOR) - December 27 at 8:48 AM
News IconSize and Share of Cardiac Assist Devices in India Industry : Insights, Development, Research and Forecast 2016-2020 (NASDAQ:THOR) - December 23 at 1:50 AM
News IconResearch Analysis on Artificial Organs and Bionics Market Overview and forecast 2016 to 2021 (NASDAQ:THOR) - December 17 at 3:24 AM
News IconMedtech M&A in 2016: Deals and Dilemmas (NASDAQ:THOR) - December 12 at 8:19 PM
News IconCardiac Assist Devices Market Size, Analysis, and Forecast Report 2015-2025 (NASDAQ:THOR) - December 9 at 8:06 PM
News IconDr. Michael Ennen (NASDAQ:THOR) - December 6 at 7:16 AM
News IconCardiac Assist Devices Market Shares, Strategies and Forecast Worldwide, 2015 to 2025 (NASDAQ:THOR) - December 6 at 7:16 AM logoArtificial Organ Bank Market: Number of people waiting for organ transplantation are the main factors responsible to drive the market (NASDAQ:THOR) - November 16 at 11:46 AM logoArtificial Organs Market Is Progressing Towards a Strong Growth by 2021 - Persistence Market Research (NASDAQ:THOR) - November 4 at 7:28 PM
News IconCardiac Assist Devices Market to be Propelled by Rapidly Growing Geriatric Population (NASDAQ:THOR) - October 28 at 7:29 PM
News IconUnited States Intravenous Membrane Oxygenator Market Report 2016 (NASDAQ:THOR) - October 20 at 12:13 PM
News IconCardiac Assist Devices Market Size, Share and Forecast - 2019 (NASDAQ:THOR) - October 13 at 7:52 PM logoGlobal Cardiac Assist Devices Market Size, Share and Forecast - 2019 (NASDAQ:THOR) - October 13 at 11:36 AM
News IconGlobal Extracorporeal Liver Assist Device (ELAD) Sales Market Report 2016: Terumo Heart, Baxter International, Thoratec Corp., Abbott Diabetes Care (NASDAQ:THOR) - October 7 at 10:10 AM logoWinnebago Shares Surge 22% On Grand Design Acquisition, Baird Upgrade (NASDAQ:THOR) - October 3 at 7:07 PM
News IconGlobal LVAD Market Report: 2015 Edition | Now Available at (NASDAQ:THOR) - October 1 at 11:20 AM
News IconGlobal left ventricular assist systems (LVAS) market forecast to 2021 just published (NASDAQ:THOR) - September 28 at 7:26 PM
News Icon2016 Global Bio-Artificial Systems Industry 2021 Forecast Report (NASDAQ:THOR) - September 28 at 7:26 PM logoGlobal Artificial Organs Industry - Annual estimates and forecasts 2015 - 2022 (NASDAQ:THOR) - September 26 at 7:40 PM
News IconAustria Cardiac Assist Devices Market Outlook to 2022 - New Study Released (NASDAQ:THOR) - September 23 at 7:02 PM logoImpact of Existing and Emerging Cardiac Assist Devices Market Trends And Forecast 2015-2025 (NASDAQ:THOR) - September 23 at 7:02 PM
News IconCardiac Assist Devices Market Intelligence Report Offers Growth Prospects (NASDAQ:THOR) - September 15 at 7:47 PM
News IconCardiac Assist Devices Industry Global Research Report 2016 (NASDAQ:THOR) - September 15 at 7:47 PM logoGlobal Cardiac Assist Devices Market Analysis 2016 Forecasts to 2021 (NASDAQ:THOR) - September 13 at 9:53 AM logoReleases New Report on the Global Cardiac Assist Devices Market (NASDAQ:THOR) - September 6 at 7:47 PM


What is Thoratec's stock symbol?

Thoratec trades on the NASDAQ under the ticker symbol "THOR."

When will Thoratec announce their earnings?

Thoratec is scheduled to release their next quarterly earnings announcement on Tuesday, November, 3rd 2015.

How do I buy Thoratec stock?

Shares of Thoratec can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Thoratec stock cost?

One share of Thoratec stock can currently be purchased for approximately $63.50.

Thoratec (NASDAQ:THOR) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Thoratec (NASDAQ:THOR)

Earnings History Chart

Earnings by Quarter for Thoratec (NASDAQ:THOR)

Dividend History Chart

Dividend Payments by Quarter for Thoratec (NASDAQ:THOR)

Last Updated on 2/25/2017 by Staff